v3.25.2
Statements of Cash Flows - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities:          
Net loss   $ (11,410,000) $ (15,426,000) $ (11,410,000) $ (15,426,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   1,628,000 618,000    
Depreciation and amortization expense   183,000 81,000    
Issuance of common stock, net of discount for lack of marketability   101,000 0    
Warrant expense - termination agreement   0 4,556,000 0 4,556,000
Warrant liability - mark-to-market   0 3,444,000 (0) 3,444,000
Changes in operating assets - (increase)/decrease:          
Other current assets   310,000 (478,000)    
Changes in operating liabilities - increase:          
Accounts payable   184,000 320,000    
Accrued expenses   746,000 237,000    
Net cash used in operating activities   (8,258,000) (6,648,000) (8,300,000) (6,600,000)
Cash Flows from Investing Activities:          
Purchase of property and equipment   (14,000) (19,000)    
Net cash used in investing activities   (14,000) (19,000)    
Cash Flows from Financing Activities (increase/decrease):          
Issuance of common stock, pre-funded and common warrants   10,025,000 0    
Payment of issuance costs for financing   (1,052,000) 0 (1,100,000)  
Payment of issuance costs for registration statement   (176,000) 0 (200,000)  
Proceeds from exercise of warrants   1,000 0    
Issuance of convertible debt   0 2,000,000    
Issuance of common stock from IPO   0 10,866,000    
Payment of issuance costs for IPO   0 (1,296,000)   (1,300,000)
Net cash provided by financing activities   8,800,000 14,410,000    
Net change in cash and cash equivalents   528,000 7,743,000    
Cash and cash equivalents, at beginning of period   8,608,000 865,000 8,608,000  
Cash and cash equivalents, at end of period $ 9,136,000 9,136,000 8,608,000 9,136,000 8,608,000
Non-cash financing activities:          
Warrants issued for equity issuance costs   479,000 0    
Proceeds from cashless exercise of warrants   39,000 2,000    
Warrants issued for debt issuance costs   0 577,000    
Fair value of warrants issued for issuance costs as part of IPO   0 225,000    
Holdback of IPO proceeds   0 305,000    
Issuance of Common Stock for Extinguishment of Convertible Debt [Member]          
Non-cash financing activities:          
Convertible notes converted into common stock   1,330,000 670,000 1,330,000  
Settlement/conversion to common shares for debt issuance costs   (153,000) (170,000) $ (153,000)  
ATM Agreement [Member]          
Cash Flows from Financing Activities (increase/decrease):          
Proceeds from issuance of common stock 1,746 2,000 0    
Proceeds from issuance of common stock $ 1,746 2,000 0    
Private Placement [Member]          
Cash Flows from Financing Activities (increase/decrease):          
Payment of issuance costs for registration statement         $ 0
Proceeds from issuance of common stock   0 2,840,000    
Proceeds from issuance of common stock   $ 0 $ 2,840,000